Heme induced oxidative stress attenuates sirtuin1 and enhances adipogenesis in mesenchymal stem cells and mouse pre-adipocytes

Journal of Cellular Biochemistry

Volumn 113, Issue 6, 2012, Pages 1926-1935

  Puri, Nitin ^a   Sodhi, Komal ^a   Haarstad, Michael ^a   Kim, Dong Hyun ^a   Bohinc, Steven ^a   Foglio, Eleonora ^a   Favero, Gaia ^a   Abraham, Nader G ^a  

^a MEDICAL COLLEGE OF OHIO   (United States)

Author keywords

3T3L1; ADIPOGENESIS; HEME; OXIDATIVE STRESS; TEMPOL

Indexed keywords

ADIPONECTIN; CCAAT ENHANCER BINDING PROTEIN ALPHA; HEME; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; SIRTUIN 1; SUPEROXIDE DISMUTASE; TEMPOL; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR AP 2;

ADIPOCYTE; ADIPOGENESIS; ANIMAL CELL; ARTICLE; CONTROLLED STUDY; GENE OVEREXPRESSION; HUMAN; HUMAN TISSUE; MESENCHYMAL STEM CELL; MOUSE; NONHUMAN; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROADIPOCYTE; PROTEIN EXPRESSION;

3T3-L1 CELLS; ADIPOCYTES; ADIPOGENESIS; ADIPONECTIN; ANIMALS; ANTIOXIDANTS; CCAAT-ENHANCER-BINDING PROTEIN-ALPHA; CELL LINE; CYCLIC N-OXIDES; FATTY ACID-BINDING PROTEINS; HEME; HUMANS; MESENCHYMAL STROMAL CELLS; MICE; OXIDATIVE STRESS; PPAR GAMMA; REACTIVE OXYGEN SPECIES; SIGNAL TRANSDUCTION; SIRTUIN 1; SPIN LABELS;

EID: 84859590527     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.24061     Document Type: Article

References (35)

1. Abraham NG, Kappas A,. 2008. Pharmacological and clinical aspects of heme oxygenase. Pharmacol Rev 60: 79-127.
2. Abraham NG, Drummond GS, Lutton JD, Kappas A,. 1996. The biological significance and physiological role of heme oxygenase. Cell Physiol Biochem 6: 129-168.
3. Ahmad M, Zhao X, Kelly MR, Kandhi S, Perez O, Abraham NG, Wolin MS,. 2009. Heme oxygenase-1 induction modulates hypoxic pulmonary vasoconstriction through upregulation of ecSOD. Am J Physiol Heart Circ Physiol 297 (4): H1453-H1461.
4. Balla J, Jacob HS, Balla G, Nath K, Eaton JW, Vercellotti GM,. 1993. Endothelial-cell heme uptake from heme proteins: Induction of sensitization and desensitization to oxidant damage. Proc Natl Acad Sci USA 90: 9285-9289.
5. Barbagallo I, Vanella A, Peterson S, Kim DH, Tibullo D, Giallongo C, Vanella L, Parrinello N, Palumbo G, Di Raimondo F, Abraham NG, Asprinio D,. 2010. Overexpression of heme oxygenase-1 increases human osteoblast stem cell differentiation. J Bone Miner Metab 28: 276-288.
6. Bluher M,. 2008. The inflammatory process of adipose tissue. Pediatr Endocrinol Rev 6: 24-31.
7. Canto C, Auwerx J,. 2012. Targeting sirtuin 1 to improve metabolism: All you need is NAD+? Pharmacol Rev 64: 166-187.
8. Chen JJ, London IM,. 1981. Hemin enhances the differentiation of mouse 3T3 cells to adipocytes. Cell 26: 117-122.
9. Chung S, Yao H, Caito S, Hwang JW, Arunachalam G, Rahman I,. 2010. Regulation of SIRT1 in cellular functions: Role of polyphenols. Arch Biochem Biophys 501: 79-90.
10. Gedik CM, Boyle SP, Wood SG, Vaughan NJ, Collins AR,. 2002. Oxidative stress in humans: Validation of biomarkers of DNA damage. Carcinogenesis 23: 1441-1446.
11. Gesta S, Tseng YH, Kahn CR,. 2007. Developmental origin of fat: Tracking obesity to its source. Cell 131: 242-256.
12. Hosono T, Mizuguchi H, Katayama K, Koizumi N, Kawabata K, Yamaguchi T, Nakagawa S, Watanabe Y, Mayumi T, Hayakawa T,. 2005. RNA interference of PPAR-gamma using fiber-modified adenovirus vector efficiently suppresses preadipocyte-to-adipocyte differentiation in 3T3-L1 cells. Gene 348: 157-165.
13. Iyer A, Fairlie DP, Prins JB, Hammock BD, Brown L,. 2010. Inflammatory lipid mediators in adipocyte function and obesity. Nat Rev Endocrinol 6: 71-82.
14. Kim JR, Ryu HH, Chung HJ, Lee JH, Kim SW, Kwun WH, Baek SH, Kim JH,. 2006. Association of anti-obesity activity of N-acetylcysteine with metallothionein-II down-regulation. Exp Mol Med 38: 162-172.
15. Kim DH, Vanella L, Inoue K, Burgess A, Gotlinger K, Manthati VL, Koduru SR, Zeldin DC, Falck JR, Schwartzman ML, Abraham NG,. 2010. EET-agonist regulates human mesenchymal stem cells-derived adipocytes through activation of HO-1-pAKT signaling and a decrease in PPAR-gamma. Stem Cells Dev 19 (12): 1863-1873.
16. Kloting N, Schleinitz D, Ruschke K, Berndt J, Fasshauer M, Tonjes A, Schon MR, Kovacs P, Stumvoll M, Bluher M,. 2008. Inverse relationship between obesity and FTO gene expression in visceral adipose tissue in humans. Diabetologia 51: 641-647.
17. Laniado-Schwartzman M, Abraham NG, Sacerdoti D, Escalante B, McGiff JC,. 1992. Effect of acute and chronic treatment of tin on blood pressure in spontaneously hypertensive rats. Tohoku J Exp Med 166: 85-91.
18. Li M, Kim DH, Tsenovoy PL, Peterson SJ, Rezzani R, Rodella LF, Aronow WS, Ikehara S, Abraham NG,. 2008. Treatment of obese diabetic mice with a heme oxygenase inducer reduces visceral and subcutaneous adiposity, increases adiponectin levels, and improves insulin sensitivity and glucose tolerance. Diabetes 57: 1526-1535.
19. MacDougald OA, Lane MD,. 1995. Transcriptional regulation of gene expression during adipocyte differentiation. Annu Rev Biochem 64: 345-373.
20. Marchesi C, Ebrahimian T, Angulo O, Paradis P, Schiffrin EL,. 2009. Endothelial nitric oxide synthase uncoupling and perivascular adipose oxidative stress and inflammation contribute to vascular dysfunction in a rodent model of metabolic syndrome. Hypertension 54: 1384-1392.
21. Nath KA, Grande JP, Croatt AJ, Likely S, Hebbel RP, Enright H,. 1998. Intracellular targets in heme protein-induced renal injury. Kidney Int 53: 100-111.
22. Nicolai A, Li M, Kim DH, Peterson SJ, Vanella L, Positano V, Gastaldelli A, Rezzani R, Rodella LF, Drummond G, Kusmic C, L'Abbate A, Kappas A, Abraham NG,. 2009. Heme oxygenase-1 induction remodels adipose tissue and improves insulin sensitivity in obesity-induced diabetic rats. Hypertension 53: 508-515.
23. Pausova Z,. 2006. From big fat cells to high blood pressure: A pathway to obesity-associated hypertension. Curr Opin Nephrol Hypertens 15: 173-178.
24. Peterson SJ, Drummond G, Kim DH, Li M, Kruger AL, Ikehara S, Abraham NG,. 2008. L-4F treatment reduces adiposity, increases adiponectin levels and improves insulin sensitivity in obese mice. J Lipid Res 49: 1658-1669.
25. Picard F, Kurtev M, Chung N, Topark-Ngarm A, Senawong T, hado De OR, Leid M, McBurney MW, Guarente L,. 2004. Sirt1 promotes fat mobilization in white adipocytes by repressing PPAR-gamma. Nature 429: 771-776.
26. Ponka P,. 1999. Cell biology of heme. Am J Med Sci 318: 241-256.
27. Rosen ED, MacDougald OA,. 2006. Adipocyte differentiation from the inside out. Nat Rev Mol Cell Biol 7: 885-896.
28. Rosen ED, Sarraf P, Troy AE, Bradwin G, Moore K, Milstone DS, Spiegelman BM, Mortensen RM,. 1999. PPAR-gamma is required for the differentiation of adipose tissue in vivo and in vitro. Mol Cell 4: 611-617.
29. Rosen ED, Hsu CH, Wang X, Sakai S, Freeman MW, Gonzalez FJ, Spiegelman BM,. 2002. C/EBP-alpha induces adipogenesis through PPAR-gamma: A unified pathway. Genes Dev 16: 22-26.
30. Singh NP, Tice RR, Stephens RE, Schneider EL,. 1991. A microgel electrophoresis technique for the direct quantitation of DNA damage and repair in individual fibroblasts cultured on microscope slides. Mutat Res 252: 289-296.
31. Skurk T, berti-Huber C, Herder C, Hauner H,. 2007. Relationship between adipocyte size and adipokine expression and secretion. J Clin Endocrinol Metab 92: 1023-1033.
32. Spalding KL, Arner E, Westermark PO, Bernard S, Buchholz BA, Bergmann O, Blomqvist L, Hoffstedt J, Naslund E, Britton T, Concha H, Hassan M, Ryden M, Frisen J, Arner P,. 2008. Dynamics of fat cell turnover in humans. Nature 453: 783-787.
33. Tracz MJ, Alam J, Nath KA,. 2007. Physiology and pathophysiology of heme: Implications for kidney disease. J Am Soc Nephrol 18: 414-420.
34. Tsiftsoglou AS, Tsamadou AI, Papadopoulou LC,. 2006. Heme as key regulator of major mammalian cellular functions: Molecular, cellular, and pharmacological aspects. Pharmacol Ther 111: 327-345.
35. Vanella L, Kim DH, Sodhi K, Barbagallo I, Burgess AP, Falck JR, Schwartzman ML, Abraham NG,. 2011. Crosstalk between EET and HO-1 downregulates Bach1 and adipogenic marker expression in mesenchymal stem cell derived adipocytes. Prostaglandins Other Lipid Mediat 96: 54-62.